Provide subject matter expertise (SME) from Discovery through Phase 2 development for novel approaches using technology for early identification of infection
Provide lead SME support to BARDA’s Post-exposure, Pre-symptomatic Surveillance and Identification (PEPSI) Accelerator for promising solutions
Provide broad support to BARDA Division of Research, Innovation and Ventures (DRIVe) associated with identifying and validating surrogate or pathogen specific early biomarker indicators that can be leveraged for in-home or wearable diagnostic and indicator devices.
Provide expert advice and opinion on the development of new hardware, assays, and experimental techniques to test and develop next generation biochemical and/or biophysical sensors and nontraditional platforms including support to expand the ecosystem of post-exposure and pre-symptomatic detection.
Focus on leveraging data science, machine learning, analytics, and bio-engineering coupled with near or on-patient devices & capabilities.
Support BARDA’s expanding collaborations with NIH, DOD, and Non-Governmental Organizations (NGOs) in defining, aligning and driving future strategies, emerging areas of related science, knowledge assessments, innovation from related fields and critical partnerships necessary to realize successful research and development of new solutions for post-exposure, pre-symptomatic detection modalities.
Review, evaluate and support potential products for the early identification of infection in relation to scientific feasibility, risks and mitigation strategies and requirements for entrance into the PEPSI Accelerator and/or BARDA in alignment with BARDA’s national security priorities.
Facilitate and monitor progress in the establishment and management of a new PEPSI Accelerator organization.
Subject matter expert with 15-20years of preclinical, clinical (or highly related field such as infectious disease, immunology, microbiology and/or front-end design and engineering/computer sciences) R&D experience focused on the development of new nontraditional medical and healthcare diagnostics
Experience leading early stage project development (early discovery through Phase 2)
Understanding of R&D approaches, regulatory expectations and future clinical uses required
Biopharmaceutical industry experiencepreferred (or extensive industry engagement)
Program strategy and planning experiencedesired
Accomplished matrix leadership skills, inquisitive scientific thought process, natural collaborative instincts, sound interpersonal relationship skills and a strong communication presence are necessary for success in this role.